Binding of [3H] (2S,1′S,2′S)-2-(9-xanthylmethyl)-2-(2′-carboxycycloprophyl) glycine ([3H]LY341495) to cell membranes expressing recombinant human group III metabotropic glutamate receptor subtypes

被引:48
作者
Wright, RA [1 ]
Arnold, MB [1 ]
Wheeler, WJ [1 ]
Ornstein, PL [1 ]
Schoepp, DD [1 ]
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
LY341495; metabotropic glutamate receptors; group III mGlu receptors; radioligand; receptor binding;
D O I
10.1007/s002100000305
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
LY341495 is a highly potent and selective antagonist for group II mGlu receptors (mGlu2 and mGglu3). High affinity binding of [H-3]LY341495 to recombinant human group II mGlu receptors (mGlu2 and mGlu3), and in rat brain homogenates (K-d similar to 1 nM), has been previously described. Although LY341495 is a very selective nM-potent antagonist for group II mGlu receptors, it is also a relatively potent antagonist for group III mGlu receptors at high nanomolar to low micromolar concentrations. In this study we examined and characterized the binding of [H-3]LY341495 to membranes of cells expressing recombinant human group III mGlu receptors. Using up to 100 nM of [H-3]LY341495, the level of specific binding in human mGlu4a receptor-expressing cell membranes was not appreciable and binding to this site was not examined further. In contrast, we demonstrated sufficient specific binding of [H-3]LY341495 to human mGlu6, mGlu7a and mGlu8a receptor-expressing cell membranes to allow for further characterizations. [H-3]LY341495 binding was saturable and rapidly reversible. [H-3]LY341495 bound to a single site in each cell line, with K-d and B-max values of 31.6+/-6.8 nM and 3.3+/-0.7 pmol/mg protein (mGlu6), 72.7+/-22.0 nM and 3.7+/-0.4 pmol/mg protein (mGlu8a), and 14.0+/-1.1 nM and 3.0+/-0.2 pmol/mg protein (mGlu8a), [H-3]LY341495 binding to mGlu6, 7a and 7a was displaceable by compounds which interact functionally with group III mGlu receptors. For example, L-AP4 displaced [H-3]LY341495 with Ki values of 6.8+/-3.1 muM (mGlu6), 211+/-43 muM (mGlu7a) and 1.6+/-0.3 muM (mGlu8a). With L-glutamate, we obtained K-i values of 12.3+/-3.5, 869+/-154 and 4.5+/-0.83 muM, for mGlu6, mGlu7a and mGlu8a, respectively. K-i values for unlabelled LY341495 were 0.058+/-0.008, 0.22+/-0.05 and 0.029+/-0.008 muM, respectively. These studies demonstrated that [H-3]LY341495 is a useful radioligand for studying the pharmacology and expression of recombinant mGlu6, 7a and 8a receptors in cell lines.
引用
收藏
页码:546 / 554
页数:9
相关论文
共 39 条
[1]   (S)-Homo-AMPA, a specific agonist at the mGlu(6) subtype of metabotropic glutamic acid receptors [J].
Ahmadian, H ;
Nielsen, B ;
Brauner-Osborne, H ;
Johansen, TN ;
Stensbol, TB ;
Slok, FA ;
Sekiyama, N ;
Nakanishi, S ;
KrogsgaardLarsen, P ;
Madsen, U .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (22) :3700-3705
[2]   Comparative effect of L-CCG-I, DCG-IV and γ-carboxy-L-glutamate on all cloned metabotropic glutamate receptor subtypes [J].
Brabet, I ;
Parmentier, ML ;
De Colle, C ;
Bockaert, J ;
Acher, F ;
Pin, JP .
NEUROPHARMACOLOGY, 1998, 37 (08) :1043-1051
[3]   A new highly selective metabotropic excitatory amino acid agonist: 2-amino-4-(3-hydroxy-5-methylisoxazol-4-yl)butyric acid [J].
Brauner-Osborne, H ;
Slok, FA ;
Skjaerbaek, N ;
Ebert, B ;
Sekiyama, N ;
Nakanishi, S ;
KrogsgaardLarsen, P .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (16) :3188-3194
[4]   A CONFORMATIONALLY CONSTRAINED COMPETITIVE INHIBITOR OF THE SODIUM-DEPENDENT GLUTAMATE TRANSPORTER IN FOREBRAIN SYNAPTOSOMES - L-ANTI-ENDO-3,4-METHANOPYRROLIDINE DICARBOXYLATE [J].
BRIDGES, RJ ;
LOVERING, FE ;
KOCH, H ;
COTMAN, CW ;
CHAMBERLIN, AR .
NEUROSCIENCE LETTERS, 1994, 174 (02) :193-197
[5]  
DESAI MA, 1995, MOL PHARMACOL, V48, P648
[6]   Molecular cloning, functional expression, pharmacological characterization and chromosomal localization of the human metabotropic glutamate receptor type 3 [J].
Emile, L ;
Mercken, L ;
Apiou, F ;
Pradier, L ;
Bock, MD ;
Menager, J ;
Clot, J ;
Doble, A ;
Blanchard, JC .
NEUROPHARMACOLOGY, 1996, 35 (05) :523-530
[7]  
ERICKSEN L, 1995, BRIT J PHARMACOL, V116, P3279
[8]  
Flor P. J., 1998, Society for Neuroscience Abstracts, V24, P1089
[9]   MOLECULAR-CLONING, FUNCTIONAL EXPRESSION AND PHARMACOLOGICAL CHARACTERIZATION OF THE HUMAN METABOTROPIC GLUTAMATE-RECEPTOR TYPE-4 [J].
FLOR, PJ ;
LUKIC, S ;
RUEGG, D ;
LEONHARDT, T ;
KNOPFEL, T ;
KUHN, R .
NEUROPHARMACOLOGY, 1995, 34 (02) :149-155
[10]  
FORSYTHE D, 1997, CURR BIOL, V7, pR362